1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Insulin Delivery - Pipeline Review, 2015

Insulin Delivery - Pipeline Review, 2015

  • May 2015
  • -
  • Global Data
  • -
  • 196 pages

Insulin Delivery - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Insulin Delivery - Pipeline Review, 2015" provides an overview of Insulin Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Insulin Delivery products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Insulin Delivery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Insulin Delivery - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Insulin Delivery Overview 7
3 Products under Development 8
3.1 Insulin Delivery - Pipeline Products by Stage of Development 8
3.2 Insulin Delivery - Pipeline Products by Segment 9
3.3 Insulin Delivery - Pipeline Products by Territory 10
3.4 Insulin Delivery - Pipeline Products by Regulatory Path 11
3.5 Insulin Delivery - Pipeline Products by Estimated Approval Date 12
3.6 Insulin Delivery - Ongoing Clinical Trials 13
4 Insulin Delivery - Pipeline Products under Development by Companies 14
4.1 Insulin Delivery Companies - Pipeline Products by Stage of Development 14
4.2 Insulin Delivery - Pipeline Products by Stage of Development 16
5 Insulin Delivery Companies and Product Overview 17
5.1 Amrita Vishwa Vidyapeetham Company Overview 17
5.1.1 Amrita Vishwa Vidyapeetham Pipeline Products and Ongoing Clinical Trials Overview 17
5.2 Andain, Inc Company Overview 18
5.2.1 Andain, Inc Pipeline Products and Ongoing Clinical Trials Overview 18
5.3 AstraZeneca PLC Company Overview 20
5.3.1 AstraZeneca PLC Pipeline Products and Ongoing Clinical Trials Overview 20
5.4 Becton, Dickinson and Company Company Overview 22
5.4.1 Becton, Dickinson and Company Pipeline Products and Ongoing Clinical Trials Overview 22
5.5 Cellnovo Ltd. Company Overview 24
5.5.1 Cellnovo Ltd. Pipeline Products and Ongoing Clinical Trials Overview 24
5.6 CeQur SA Company Overview 26
5.6.1 CeQur SA Pipeline Products and Ongoing Clinical Trials Overview 26
5.7 Companion Medical Company Overview 29
5.7.1 Companion Medical Pipeline Products and Ongoing Clinical Trials Overview 29
5.8 ConvaTec Healthcare B S.a.r.l. Company Overview 30
5.8.1 ConvaTec Healthcare B S.a.r.l. Pipeline Products and Ongoing Clinical Trials Overview 30
5.9 Dance Biopharm Inc. Company Overview 31
5.9.1 Dance Biopharm Inc. Pipeline Products and Ongoing Clinical Trials Overview 31
5.10 Debiotech S.A. Company Overview 32
5.10.1 Debiotech S.A. Pipeline Products and Ongoing Clinical Trials Overview 32
5.11 InsuLenz Company Overview 37
5.11.1 InsuLenz Pipeline Products and Ongoing Clinical Trials Overview 37
5.12 Insulet Corporation Company Overview 38
5.12.1 Insulet Corporation Pipeline Products and Ongoing Clinical Trials Overview 38
5.13 InsuLine Medical Ltd. Company Overview 40
5.13.1 InsuLine Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 40
5.14 LifeScan, Inc. Company Overview 45
5.14.1 LifeScan, Inc. Pipeline Products and Ongoing Clinical Trials Overview 45
5.15 Medical International Technologies (Mit Canada) Inc. Company Overview 47
5.15.1 Medical International Technologies (Mit Canada) Inc. Pipeline Products and Ongoing Clinical Trials Overview 47
5.16 MedSolve Technologies, Inc. Company Overview 49
5.16.1 MedSolve Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 49
5.17 MicroPort Scientific Corporation Company Overview 50
5.17.1 MicroPort Scientific Corporation Pipeline Products and Ongoing Clinical Trials Overview 50
5.18 North Carolina State University Company Overview 52
5.18.1 North Carolina State University Pipeline Products and Ongoing Clinical Trials Overview 52
5.19 Sanofi Company Overview 54
5.19.1 Sanofi Pipeline Products and Ongoing Clinical Trials Overview 54
5.20 SFC Fluidics LLC Company Overview 56
5.20.1 SFC Fluidics LLC Pipeline Products and Ongoing Clinical Trials Overview 56
5.21 Spring Health Solutions Ltd. Company Overview 57
5.21.1 Spring Health Solutions Ltd. Pipeline Products and Ongoing Clinical Trials Overview 57
5.22 Transdermal Specialties, Inc. Company Overview 59
5.22.1 Transdermal Specialties, Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
5.23 University of KwaZulu-Natal Company Overview 60
5.23.1 University of KwaZulu-Natal Pipeline Products and Ongoing Clinical Trials Overview 60
5.24 University of Toronto Company Overview 61
5.24.1 University of Toronto Pipeline Products and Ongoing Clinical Trials Overview 61
5.25 Ypsomed Holding AG Company Overview 62
5.25.1 Ypsomed Holding AG Pipeline Products and Ongoing Clinical Trials Overview 62
6 Insulin Delivery- Recent Developments 64
7 Appendix 194
7.1 Methodology 194
7.2 About GlobalData 196
7.3 Contact Us 196
7.4 Disclaimer 196

1.1 List of Tables
Table 1: Insulin Delivery - Pipeline Products by Stage of Development 8
Table 2: Insulin Delivery - Pipeline Products by Segment 9
Table 3: Insulin Delivery - Pipeline Products by Territory 10
Table 4: Insulin Delivery - Pipeline Products by Regulatory Path 11
Table 5: Insulin Delivery - Pipeline Products by Estimated Approval Date 12
Table 6: Insulin Delivery - Ongoing Clinical Trials 13
Table 7: Insulin Delivery Companies - Pipeline Products by Stage of Development 14
Table 8: Insulin Delivery - Pipeline Products by Stage of Development 16
Table 9: Amrita Vishwa Vidyapeetham Pipeline Products and Ongoing Clinical Trials Overview 17
Table 10: MEMS-based Insulin Pump - Product Status 17
Table 11: MEMS-based Insulin Pump - Product Description 17
Table 12: Andain, Inc Pipeline Products and Ongoing Clinical Trials Overview 18
Table 13: Gaia Med Diamond Insulin Pump - Product Status 18
Table 14: Gaia Med Diamond Insulin Pump - Product Description 18
Table 15: Miniature Insulin Pump - Product Status 19
Table 16: Miniature Insulin Pump - Product Description 19
Table 17: AstraZeneca PLC Pipeline Products and Ongoing Clinical Trials Overview 20
Table 18: BYDUREON Dual Chamber Pen - Product Status 20
Table 19: BYDUREON Dual Chamber Pen - Product Description 21
Table 20: Becton, Dickinson and Company Pipeline Products and Ongoing Clinical Trials Overview 22
Table 21: BD FlowSmart Infusion Set - Product Status 22
Table 22: BD FlowSmart Infusion Set - Product Description 23
Table 23: Cellnovo Ltd. Pipeline Products and Ongoing Clinical Trials Overview 24
Table 24: Cellnovo Wireless Insulin Pump System - Product Status 24
Table 25: Cellnovo Wireless Insulin Pump System - Product Description 24
Table 26: CeQur SA Pipeline Products and Ongoing Clinical Trials Overview 26
Table 27: PaQ Insulin Delivery Device - Product Status 26
Table 28: PaQ Insulin Delivery Device - Product Description 26
Table 29: CeQur SA - Ongoing Clinical Trials Overview 27
Table 30: PaQ Insulin Delivery Device - A Prospective, Single Center Study to Assess the Performance, Safety, and Patient Reported Outcomes of Insulin Delivery With PaQ in Patients With Type 2 Diabetes Mellitus 28
Table 31: PaQ Insulin Delivery Device - A Prospective, Single Center, Post-Market Observational Study to Assess the Efficacy, Safety and Patient Reported Outcomes of Insulin Delivery With PaQ in Patients With Type 2 Diabetes Mellitus 28
Table 32: Companion Medical Pipeline Products and Ongoing Clinical Trials Overview 29
Table 33: Insulin Pen - Product Status 29
Table 34: Insulin Pen - Product Description 29
Table 35: ConvaTec Healthcare B S.a.r.l. Pipeline Products and Ongoing Clinical Trials Overview 30
Table 36: Patch Pump - Product Status 30
Table 37: Patch Pump - Product Description 30
Table 38: Dance Biopharm Inc. Pipeline Products and Ongoing Clinical Trials Overview 31
Table 39: Dance 501 - Product Status 31
Table 40: Dance 501 - Product Description 31
Table 41: Debiotech S.A. Pipeline Products and Ongoing Clinical Trials Overview 32
Table 42: Integrated iSense CGM And JewelPUMP - Product Status 32
Table 43: Integrated iSense CGM And JewelPUMP - Product Description 32
Table 44: Jewel Pump - Product Status 33
Table 45: Jewel Pump - Product Description 33
Table 46: JewelPUMP2 - Product Status 34
Table 47: JewelPUMP2 - Product Description 34
Table 48: Debiotech S.A. - Ongoing Clinical Trials Overview 35
Table 49: Jewel Pump - Feasibility Study of the JewelPump Version 3 36
Table 50: InsuLenz Pipeline Products and Ongoing Clinical Trials Overview 37
Table 51: Smart Polymer Contact Lens - Product Status 37
Table 52: Smart Polymer Contact Lens - Product Description 37
Table 53: Insulet Corporation Pipeline Products and Ongoing Clinical Trials Overview 38
Table 54: OmniPod - New Version - Product Status 38
Table 55: OmniPod - New Version - Product Description 39
Table 56: InsuLine Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 40
Table 57: InsuPad - Product Status 40
Table 58: InsuPad - Product Description 41
Table 59: InsuPatch Device - Product Status 41
Table 60: InsuPatch Device - Product Description 41
Table 61: InsuLine Medical Ltd. - Ongoing Clinical Trials Overview 42
Table 62: InsuPatch Device - Effect of the Insupatch on Automated Closed-loop Glucose Control in Type 1 Diabetes 43
Table 63: InsuPatch Device - Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance 43
Table 64: InsuPad - Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the Experimental Device 44
Table 65: LifeScan, Inc. Pipeline Products and Ongoing Clinical Trials Overview 45
Table 66: 3-Day Wearable Insulin Patch - Product Status 45
Table 67: 3-Day Wearable Insulin Patch - Product Description 45
Table 68: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Status 46
Table 69: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Description 46
Table 70: Medical International Technologies (Mit Canada) Inc. Pipeline Products and Ongoing Clinical Trials Overview 47
Table 71: MIT-P-I - Product Status 47
Table 72: MIT-P-I - Product Description 48
Table 73: MedSolve Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 49
Table 74: Freehand Patch Pump - Product Status 49
Table 75: Freehand Patch Pump - Product Description 49
Table 76: MicroPort Scientific Corporation Pipeline Products and Ongoing Clinical Trials Overview 50
Table 77: La Fenice Pen - Product Status 50
Table 78: La Fenice Pen - Product Description 50
Table 79: La Fenice V - Product Status 51
Table 80: La Fenice V - Product Description 51
Table 81: North Carolina State University Pipeline Products and Ongoing Clinical Trials Overview 52
Table 82: Pulsatile Noninvasive Drug Delivery System - Product Status 52
Table 83: Pulsatile Noninvasive Drug Delivery System - Product Description 53
Table 84: Sanofi Pipeline Products and Ongoing Clinical Trials Overview 54
Table 85: Fix-Flex Device - Product Status 54
Table 86: Fix-Flex Device - Product Description 55
Table 87: SFC Fluidics LLC Pipeline Products and Ongoing Clinical Trials Overview 56
Table 88: Disposable Insulin Patch Pump - Product Status 56
Table 89: Disposable Insulin Patch Pump - Product Description 56
Table 90: Spring Health Solutions Ltd. Pipeline Products and Ongoing Clinical Trials Overview 57
Table 91: Spring Zone Hybrid Patch Pump - Product Status 57
Table 92: Spring Zone Hybrid Patch Pump - Product Description 58
Table 93: Transdermal Specialties, Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
Table 94: U-Strip Insulin Patch - Product Status 59
Table 95: U-Strip Insulin Patch - Product Description 59
Table 96: University of KwaZulu-Natal Pipeline Products and Ongoing Clinical Trials Overview 60
Table 97: Pectin Insulin Gel Skin Patch - Product Status 60
Table 98: Pectin Insulin Gel Skin Patch - Product Description 60
Table 99: University of Toronto Pipeline Products and Ongoing Clinical Trials Overview 61
Table 100: Implantable Closed-Loop Insulin Delivery Device - Product Status 61
Table 101: Implantable Closed-Loop Insulin Delivery Device - Product Description 61
Table 102: Ypsomed Holding AG Pipeline Products and Ongoing Clinical Trials Overview 62
Table 103: Lanzi - Product Status 62
Table 104: Lanzi - Product Description 63
Table 105: mylife YpsoPump - Product Status 63
Table 106: mylife YpsoPump - Product Description 63
Table 107: Glossary 195

1.2 List of Figures
Figure 1: Insulin Delivery - Pipeline Products by Stage of Development 8
Figure 2: Insulin Delivery - Pipeline Products by Segment 9
Figure 3: Insulin Delivery - Pipeline Products by Territory 10
Figure 4: Insulin Delivery - Pipeline Products by Regulatory Path 11
Figure 5: Insulin Delivery - Pipeline Products by Estimated Approval Date 12
Figure 6: Insulin Delivery - Ongoing Clinical Trials 13

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.